Maple Capital Management Inc. Has $20.84 Million Stake in Intuitive Surgical, Inc. $ISRG

Maple Capital Management Inc. reduced its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 0.7% in the 2nd quarter, Holdings Channel.com reports. The institutional investor owned 38,355 shares of the medical equipment provider’s stock after selling 268 shares during the quarter. Intuitive Surgical comprises about 1.4% of Maple Capital Management Inc.’s investment portfolio, making the stock its 23rd largest position. Maple Capital Management Inc.’s holdings in Intuitive Surgical were worth $20,842,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently modified their holdings of the stock. Tobam increased its stake in Intuitive Surgical by 666.7% in the second quarter. Tobam now owns 46 shares of the medical equipment provider’s stock valued at $25,000 after purchasing an additional 40 shares in the last quarter. TD Capital Management LLC grew its holdings in shares of Intuitive Surgical by 300.0% in the 1st quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider’s stock valued at $30,000 after buying an additional 45 shares during the period. 1248 Management LLC bought a new stake in shares of Intuitive Surgical in the 1st quarter valued at $30,000. Princeton Global Asset Management LLC bought a new stake in shares of Intuitive Surgical in the 2nd quarter valued at $30,000. Finally, Bank of Jackson Hole Trust raised its stake in Intuitive Surgical by 70.5% during the 1st quarter. Bank of Jackson Hole Trust now owns 75 shares of the medical equipment provider’s stock worth $37,000 after buying an additional 31 shares during the period. 83.64% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Several equities research analysts have issued reports on the company. BTIG Research increased their price target on Intuitive Surgical from $529.00 to $589.00 and gave the stock a “buy” rating in a report on Wednesday, October 22nd. The Goldman Sachs Group raised their target price on shares of Intuitive Surgical from $567.00 to $621.00 and gave the stock a “buy” rating in a report on Wednesday, October 22nd. Jefferies Financial Group lifted their price target on Intuitive Surgical from $550.00 to $560.00 and gave the company a “hold” rating in a research note on Wednesday, October 22nd. Raymond James Financial set a $603.00 price objective on Intuitive Surgical and gave the stock an “outperform” rating in a research report on Wednesday, October 22nd. Finally, Royal Bank Of Canada set a $625.00 target price on Intuitive Surgical and gave the company an “outperform” rating in a research report on Wednesday, October 22nd. Two research analysts have rated the stock with a Strong Buy rating, nineteen have given a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and a consensus target price of $608.92.

Intuitive Surgical Stock Down 0.7%

NASDAQ:ISRG opened at $572.17 on Wednesday. Intuitive Surgical, Inc. has a twelve month low of $425.00 and a twelve month high of $616.00. The firm has a market capitalization of $205.11 billion, a price-to-earnings ratio of 75.68, a price-to-earnings-growth ratio of 4.94 and a beta of 1.62. The stock’s 50 day moving average price is $476.01 and its two-hundred day moving average price is $502.00.

Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share for the quarter, topping analysts’ consensus estimates of $1.99 by $0.41. Intuitive Surgical had a net margin of 28.58% and a return on equity of 15.08%. The business had revenue of $2.51 billion for the quarter, compared to the consensus estimate of $2.41 billion. During the same period in the previous year, the company earned $1.84 earnings per share. The firm’s revenue for the quarter was up 22.9% on a year-over-year basis. As a group, analysts anticipate that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Insiders Place Their Bets

In related news, insider Gary S. Guthart sold 2,800 shares of Intuitive Surgical stock in a transaction dated Friday, October 24th. The stock was sold at an average price of $546.27, for a total transaction of $1,529,556.00. Following the completion of the transaction, the insider owned 17,120 shares in the company, valued at approximately $9,352,142.40. This trade represents a 14.06% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, VP Fredrik Widman sold 2,067 shares of the firm’s stock in a transaction on Wednesday, November 5th. The shares were sold at an average price of $550.00, for a total value of $1,136,850.00. Following the sale, the vice president directly owned 473 shares of the company’s stock, valued at $260,150. This represents a 81.38% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold a total of 98,078 shares of company stock worth $51,445,892 in the last three months. Insiders own 0.70% of the company’s stock.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.